A naturopathic treatment approach for mild and moderate COVID-19: A retrospective chart review

Melissa S Barber1, Richard Barrett1, Ryan D Bradley1

  • 1National University of Natural Medicine, Helfgott Research Institute, 2220 SW 1st Ave, Portland, OR, United States.

Insights

This study explored a naturopathic treatment for mild to moderate COVID-19 using supplements and herbs. The approach was well-tolerated, with symptom resolution in most patients, suggesting potential clinical benefits.

Area of Science:

  • Integrative Medicine
  • Infectious Disease Research
  • Nutritional Science

Background:

  • The COVID-19 pandemic caused significant global health issues.
  • While vaccines are available, effective therapeutic options for COVID-19 remain crucial.
  • Naturopathic medicine offers potential complementary treatment strategies.

Purpose of the Study:

  • To evaluate a naturopathic treatment protocol for mild to moderate COVID-19.
  • To assess the safety and efficacy of a multi-nutrient, herbal, and probiotic approach.
  • To identify factors influencing illness duration in COVID-19 patients.

Main Methods:

  • Retrospective chart review of 30 patients with mild/moderate COVID-19.
  • Treatment included multi-nutrients, herbs, and probiotics in a primary care setting.
  • Primary outcome: treatment safety; Secondary outcomes: symptom changes, progression, long COVID, recovery time.

Main Results:

  • The naturopathic treatment was well-tolerated with no reported adverse events.
  • All patients experienced symptom resolution; one hospitalization occurred after a prolonged illness.
  • Delayed treatment and symptom severity correlated with longer illness duration.

Conclusions:

  • A multi-nutrient, herbal, and probiotic strategy appears safe and potentially beneficial for mild/moderate COVID-19.
  • Early intervention and fewer initial symptoms are linked to better outcomes.
  • Further prospective trials are warranted to confirm the clinical utility of this naturopathic approach.
Abstract

Related Concept Videos

Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
497
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
49
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
140
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.8K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
472
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
35